Page last updated: 2024-11-01

ofloxacin and Fungal Lung Diseases

ofloxacin has been researched along with Fungal Lung Diseases in 5 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research Excerpts

ExcerptRelevanceReference
"A case of allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans in a 48 year old man was discussed."1.38A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans. ( Datau, EA, 2012)
"Amoxicillin was prescribed in 108 cases, fluoroquinolone in 24 cases, macrolide in 18 cases."1.36[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia]. ( Bernardin, G; Cua, E; de Salvador, F; Dellamonica, J; Hyvernat, H; Landraud, L; Risso, K; Roger, PM; Vassallo, M, 2010)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Katsuki, Y1
Motoishi, M1
Tsutiya, M1
Enokibori, T1
Ninomiya, K1
Roger, PM1
Risso, K1
Hyvernat, H1
Landraud, L1
Vassallo, M1
Dellamonica, J1
de Salvador, F1
Cua, E1
Bernardin, G1
Datau, EA1
Müller, M1
Fallen, H1
Zöller, L1
Weber, C1
Maas, R1
Steiner, P1
Kramer, J1
Bumann, D1
Zander, AR1
Bücheler, E1

Other Studies

5 other studies available for ofloxacin and Fungal Lung Diseases

ArticleYear
[Pulmonary nocardiosis in a patient with diffuse panbronchiolitis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2009, Volume: 47, Issue:4

    Topics: Bronchiolitis; Drug Therapy, Combination; Humans; Lung Diseases, Fungal; Male; Middle Aged; Nocardia

2009
[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:6

    Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Cohort Studies; Co

2010
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
    Acta medica Indonesiana, 2012, Volume: 44, Issue:4

    Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Bu

2012
[Pulmonary aspergillosis in an immunocompetent female patient].
    Deutsche medizinische Wochenschrift (1946), 1994, May-27, Volume: 119, Issue:21

    Topics: Administration, Inhalation; Aspergillosis; Aspergillus fumigatus; Azlocillin; Bronchi; Bronchoscopy;

1994
[Importance of digital thoracic radiography in the diagnosis of pulmonary infiltrates in patients with bone marrow transplantation during aplasia].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1999, Volume: 171, Issue:4

    Topics: Adult; Anemia, Aplastic; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Bone Marr

1999